Increased mortality in type II diabetic patients using sulphonylurea and metformin in combination: A population-based observational study

Diabetologia

Volumn 43, Issue 5, 2000, Pages 558-560

  Olsson, J ^a   Lindberg, G ^a   Gottsater M ^b   Lindwall, K ^a   Sjöstrand, Å ^c   Tisell, A ^b   Melander, A ^a  

^a Network for Pharmacoepidemiology Foundation   (Sweden)

^b Vetlanda Health Care Centre   (Sweden)

^c Tranås Health Care Centre   (Sweden)

Author keywords

Combination treatment; Metformin; Mortality; Pharmacoepidemiology; Sulphonylurea; Type II diabetes

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

BLOOD GLUCOSE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MYOCARDIAL ISCHEMIA; REGRESSION ANALYSIS; SULFONYLUREA COMPOUNDS;

EID: 0034109564     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051343     Document Type: Article

References (7)

1. 1. Hermann LS, Scherstén B, Bitzén PO, Kjellström T, Lindegärde F, Melander A (1994) Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care 10: 1100-1109
2. 2. Hermann LS, Schersten B, Melander A (1994) Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination. Diabet Med 10: 953-960
3. 3. DeFronzo RA, Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The multicenter metformin study group. N Engl J Med 333: 541-549
4. 4. Turner RC, Holman RR, Cull CA et al. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
5. 5. Turner RC, Holman RR, Cull CA et al. (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-862
6. 6. World Health Organization Study Group on Diabetes Mellitus (1985) Technical report series No 727, WHO, Geneva
7. 7. Jeppsson JO, Jerntorp P, Sundqvist G, Englund H, Nylund V (1986) Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32: 1867-1872